AcuCort is a pharmaceutical company. The company has developed and commercializes the drug Zeqmelit®, which is an oral film based on the cortisone substance dexamethasone, for quick availability and relief in severe and acute allergic reactions, among other things. The goal is commercialization in the EU, USA and in selected key markets via licensees and distributors. The company has its headquarters in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 29,14 | 29,14 | 2024-12-23 |
| Aqilion AB | 9,50 | 9,50 | 2024-12-23 |
| Jan Sören Poulsen | 5,19 | 5,19 | 2024-12-23 |
| Olle Florén med bolag | 2,85 | 2,85 | 2024-12-23 |
| Bengt Schager | 1,74 | 1,74 | 2024-12-23 |
| Zoya Invest AB | 1,71 | 1,71 | 2024-12-23 |
| Johan Thorell | 1,31 | 1,31 | 2024-12-23 |
| Berne Gilbert Okdah | 1,13 | 1,13 | 2024-12-23 |
| Handelsbanken Liv Försäkring AB | 1,03 | 1,03 | 2024-12-23 |
| Göran Ofsén | 1,01 | 1,01 | 2024-12-23 |
2025-02-21 Bokslutskommuniké 2024